ABT-888 is a potent, orally bioavailable PARP-1/-2 inhibitor shown to potentiate DNA damaging agents. The ability to potentiate temozolomide (TMZ) and develop a biological marker for PARP inhibition was evaluated in vivo.
Molecular Spectra
No Data Available
Click here to submit data
References
• Tentori, L., et al.: Clin. Cancer Res., 9, 5370 (2002)
• Tentori, L., et al.: Pharmacol. Res., 52, 25 (2002)
• Kim, M., et al.: Cell, 119, 803 (2002)
• Virag, L., et al.: Pharmacol. Rev., 54, 375 (2002)